Viewing Study NCT01863693


Ignite Creation Date: 2025-12-25 @ 1:13 AM
Ignite Modification Date: 2026-01-05 @ 2:35 PM
Study NCT ID: NCT01863693
Status: COMPLETED
Last Update Posted: 2018-09-17
First Post: 2013-05-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module